Xvivo Perfusion AB (publ) (STO:XVIVO)

Xvivo Perfusion AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 9, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	6,101	5,878	15,403	10,379	5,459	8,215
Market Cap Growth	-53.55%	-61.84%	48.41%	90.12%	-33.55%	-8.90%
Enterprise Value	5,934	5,722	14,978	9,810	5,150	7,936
Last Close Price	193.70	186.60	489.00	329.50	183.00	278.50
PE Ratio	242.48	233.59	89.46	113.04	296.26	1007.78
Forward PE	57.65	51.19	92.61	199.34	111.93	211.39
PS Ratio	7.51	7.24	18.73	17.37	13.15	31.80
PB Ratio	2.89	2.78	7.14	5.34	3.82	6.39
P/TBV Ratio	4.17	4.01	10.81	7.84	6.86	10.06
P/FCF Ratio	-	58.16	379.77	3172.09	564.50	-
P/OCF Ratio	60.37	58.16	138.41	224.23	195.98	-
EV/Sales Ratio	7.31	7.05	18.21	16.42	12.40	30.71
EV/EBITDA Ratio	42.85	41.32	135.06	515.41	387.15	-
EV/EBIT Ratio	67.15	64.75	167.53	1818.08	1156.32	-
EV/FCF Ratio	-	56.62	369.29	2998.27	532.54	-
Debt / Equity Ratio	0.06	0.06	0.02	0.02	0.01	0.00
Debt / EBITDA Ratio	0.90	0.90	0.28	1.06	0.51	-
Debt / FCF Ratio	1.23	1.23	0.84	9.61	1.03	-
Asset Turnover	0.34	0.34	0.36	0.30	0.25	0.19
Inventory Turnover	0.89	0.89	1.12	1.23	1.29	1.02
Quick Ratio	3.68	3.68	3.14	4.94	2.60	4.43
Current Ratio	5.77	5.77	4.58	6.15	3.47	5.24
Return on Equity (ROE)	1.18%	1.18%	8.39%	5.44%	1.36%	0.71%
Return on Assets (ROA)	2.31%	2.31%	2.43%	0.17%	0.17%	-0.87%
Return on Invested Capital (ROIC)	2.97%	3.10%	4.80%	0.40%	0.35%	-2.41%
Return on Capital Employed (ROCE)	3.90%	3.90%	4.00%	0.30%	0.30%	-1.30%
Earnings Yield	0.41%	0.43%	1.12%	0.89%	0.34%	0.10%
FCF Yield	-	1.72%	0.26%	0.03%	0.18%	-0.27%
Buyback Yield / Dilution	0.29%	0.29%	-5.73%	-1.39%	-2.04%	-6.49%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.